These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 33581729)

  • 1.
    Chen X; Liu Y; Pan D; Cao M; Wang X; Wang L; Xu Y; Wang Y; Yan J; Liu J; Yang M
    BMC Gastroenterol; 2021 Feb; 21(1):69. PubMed ID: 33581729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a New Folate-Derived Ga-68-Based PET Imaging Agent.
    Brand C; Longo VA; Groaning M; Weber WA; Reiner T
    Mol Imaging Biol; 2017 Oct; 19(5):754-761. PubMed ID: 28194631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, Radiolabeling, and Preliminary in vivo Evaluation of [
    Farn SS; Chang KW; Lin WC; Yu HM; Lin KL; Tseng YC; Chang Y; Yu CS; Lin WJ
    Drug Des Devel Ther; 2021; 15():2577-2591. PubMed ID: 34168430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Taking cyclotron
    Nelson BJB; Wilson J; Richter S; Duke MJM; Wuest M; Wuest F
    Nucl Med Biol; 2020; 80-81():24-31. PubMed ID: 32004935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of a novel 68Ga-chelate-conjugated bisphosphonate as a bone-seeking agent for PET imaging.
    Suzuki K; Satake M; Suwada J; Oshikiri S; Ashino H; Dozono H; Hino A; Kasahara H; Minamizawa T
    Nucl Med Biol; 2011 Oct; 38(7):1011-8. PubMed ID: 21982572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of single vial kits for preparation of
    Yu HM; Chan CH; Chen JH; Chien CY; Wang PY; Juan WC; Yang CH; Hsia HT; Wang MH; Lin WJ
    J Labelled Comp Radiopharm; 2018 Oct; 61(12):885-894. PubMed ID: 30089196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 68Ga-labeling and in vivo evaluation of a uPAR binding DOTA- and NODAGA-conjugated peptide for PET imaging of invasive cancers.
    Persson M; Madsen J; Østergaard S; Ploug M; Kjaer A
    Nucl Med Biol; 2012 May; 39(4):560-9. PubMed ID: 22172391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical evaluation of 68Ga-labeled 1,4,7-triazacyclononane-1,4,7-triacetic acid-ubiquicidin as a radioligand for PET infection imaging.
    Ebenhan T; Zeevaart JR; Venter JD; Govender T; Kruger GH; Jarvis NV; Sathekge MM
    J Nucl Med; 2014 Feb; 55(2):308-14. PubMed ID: 24434293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of two new angiogenesis PET tracers 68Ga-NODAGA-E[c(RGDyK)]2 and (64)Cu-NODAGA-E[c(RGDyK)]2; in vivo imaging studies in human xenograft tumors.
    Oxboel J; Brandt-Larsen M; Schjoeth-Eskesen C; Myschetzky R; El-Ali HH; Madsen J; Kjaer A
    Nucl Med Biol; 2014 Mar; 41(3):259-67. PubMed ID: 24417983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation of Ga-68-NOTA as a renal PET agent and feasibility tests in mice.
    Lee JY; Jeong JM; Kim YJ; Jeong HJ; Lee YS; Lee DS; Chung JK
    Nucl Med Biol; 2014 Feb; 41(2):210-5. PubMed ID: 24388044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of novel gallium-68 labeled rhodamine: A potential PET myocardial perfusion agent.
    Jammaz IA; Al-Otaibi B; Al-Hokbani N; Okarvi SM
    Appl Radiat Isot; 2019 Feb; 144():29-33. PubMed ID: 30508730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation of a promising angiogenesis PET imaging agent: 68Ga-labeled c(RGDyK)-isothiocyanatobenzyl-1,4,7-triazacyclononane-1,4,7-triacetic acid and feasibility studies in mice.
    Jeong JM; Hong MK; Chang YS; Lee YS; Kim YJ; Cheon GJ; Lee DS; Chung JK; Lee MC
    J Nucl Med; 2008 May; 49(5):830-6. PubMed ID: 18413379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive Detection of HER2 Expression in Gastric Cancer by
    Guo X; Zhu H; Zhou N; Chen Z; Liu T; Liu F; Xu X; Jin H; Shen L; Gao J; Yang Z
    Mol Pharm; 2018 Nov; 15(11):5174-5182. PubMed ID: 30251865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a Ga-68 labeled PET tracer with short linker for prostate-specific membrane antigen (PSMA) targeting.
    Moon SH; Hong MK; Kim YJ; Lee YS; Lee DS; Chung JK; Jeong JM
    Bioorg Med Chem; 2018 May; 26(9):2501-2507. PubMed ID: 29655611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [
    Pauwels E; Cleeren F; Tshibangu T; Koole M; Serdons K; Dekervel J; Van Cutsem E; Verslype C; Van Laere K; Bormans G; Deroose CM
    Eur J Nucl Med Mol Imaging; 2020 Dec; 47(13):3033-3046. PubMed ID: 32617641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detecting Vulnerable Atherosclerotic Plaques by
    Jiang L; Zhu H; Li Y; Wu X; Wang H; Cheng Z
    Mol Pharm; 2019 Mar; 16(3):1350-1357. PubMed ID: 30742442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting of MMP2 activity in malignant tumors with a 68Ga-labeled gelatinase inhibitor cyclic peptide.
    Liu Q; Pan D; Cheng C; Zhang A; Ma C; Wang L; Zhang D; Liu H; Jiang H; Wang T; Xu Y; Yang R; Chen F; Yang M; Zuo C
    Nucl Med Biol; 2015 Dec; 42(12):939-44. PubMed ID: 26344861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of 68Ga-labeled mannosylated human serum albumin (MSA) as a lymph node imaging agent for positron emission tomography.
    Choi JY; Jeong JM; Yoo BC; Kim K; Kim Y; Yang BY; Lee YS; Lee DS; Chung JK; Lee MC
    Nucl Med Biol; 2011 Apr; 38(3):371-9. PubMed ID: 21492786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, Synthesis, and Biological Evaluation of
    Liu F; Liu T; Xu X; Guo X; Li N; Xiong C; Li C; Zhu H; Yang Z
    Mol Pharm; 2018 Feb; 15(2):619-628. PubMed ID: 29278911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positron Emission Tomography Imaging of Prostate Cancer with Ga-68-Labeled Gastrin-Releasing Peptide Receptor Agonist BBN
    Cheng S; Lang L; Wang Z; Jacobson O; Yung B; Zhu G; Gu D; Ma Y; Zhu X; Niu G; Chen X
    Bioconjug Chem; 2018 Feb; 29(2):410-419. PubMed ID: 29254329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.